168 related articles for article (PubMed ID: 24632612)
21. Use of mouse mammary tumour virus (MMTV)/neu transgenic mice to identify genes collaborating with the c-erbB-2 oncogene in mammary tumour development.
Jolicoeur P; Bouchard L; Guimond A; Ste-Marie M; Hanna Z; Dievart A
Biochem Soc Symp; 1998; 63():159-65. PubMed ID: 9513720
[TBL] [Abstract][Full Text] [Related]
22. Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors.
Zhang C; Mori M; Gao S; Li A; Hoshino I; Aupperlee MD; Haslam SZ; Xiao H
Cancer Res; 2010 Dec; 70(24):10224-33. PubMed ID: 21159643
[TBL] [Abstract][Full Text] [Related]
23. Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1.
Muraoka RS; Koh Y; Roebuck LR; Sanders ME; Brantley-Sieders D; Gorska AE; Moses HL; Arteaga CL
Mol Cell Biol; 2003 Dec; 23(23):8691-703. PubMed ID: 14612410
[TBL] [Abstract][Full Text] [Related]
24. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.
Miwa HE; Koba WR; Fine EJ; Giricz O; Kenny PA; Stanley P
Glycobiology; 2013 Dec; 23(12):1477-90. PubMed ID: 24037315
[TBL] [Abstract][Full Text] [Related]
25. Live imaging of extracellular signal-regulated kinase and protein kinase A activities during thrombus formation in mice expressing biosensors based on Förster resonance energy transfer.
Hiratsuka T; Sano T; Kato H; Komatsu N; Imajo M; Kamioka Y; Sumiyama K; Banno F; Miyata T; Matsuda M
J Thromb Haemost; 2017 Jul; 15(7):1487-1499. PubMed ID: 28453888
[TBL] [Abstract][Full Text] [Related]
26. Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors.
Roussos ET; Wang Y; Wyckoff JB; Sellers RS; Wang W; Li J; Pollard JW; Gertler FB; Condeelis JS
Breast Cancer Res; 2010; 12(6):R101. PubMed ID: 21108830
[TBL] [Abstract][Full Text] [Related]
27. Autocrine PDGFR signaling promotes mammary cancer metastasis.
Jechlinger M; Sommer A; Moriggl R; Seither P; Kraut N; Capodiecci P; Donovan M; Cordon-Cardo C; Beug H; Grünert S
J Clin Invest; 2006 Jun; 116(6):1561-70. PubMed ID: 16741576
[TBL] [Abstract][Full Text] [Related]
28. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
Rudolph-Owen LA; Chan R; Muller WJ; Matrisian LM
Cancer Res; 1998 Dec; 58(23):5500-6. PubMed ID: 9850086
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of peroxisome proliferator-activated receptor gamma increases estrogen receptor-dependent tumor specification.
Yin Y; Yuan H; Zeng X; Kopelovich L; Glazer RI
Cancer Res; 2009 Jan; 69(2):687-94. PubMed ID: 19147585
[TBL] [Abstract][Full Text] [Related]
30. The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis.
Shepherd TG; Kockeritz L; Szrajber MR; Muller WJ; Hassell JA
Curr Biol; 2001 Nov; 11(22):1739-48. PubMed ID: 11719215
[TBL] [Abstract][Full Text] [Related]
31. N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties.
Qian X; Anzovino A; Kim S; Suyama K; Yao J; Hulit J; Agiostratidou G; Chandiramani N; McDaid HM; Nagi C; Cohen HW; Phillips GR; Norton L; Hazan RB
Oncogene; 2014 Jun; 33(26):3411-21. PubMed ID: 23975425
[TBL] [Abstract][Full Text] [Related]
32. Partial regression, yet incomplete eradication of mammary tumors in transgenic mice by retrovirally mediated HSVtk transfer 'in vivo'.
Sacco MG; Benedetti S; Duflot-Dancer A; Mesnil M; Bagnasco L; Strina D; Fasolo V; Villa A; Macchi P; Faranda S; Vezzoni P; Finocchiaro G
Gene Ther; 1996 Dec; 3(12):1151-6. PubMed ID: 8986442
[TBL] [Abstract][Full Text] [Related]
33. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.
McHenry PR; Sears JC; Herrick MP; Chang P; Heckman-Stoddard BM; Rybarczyk M; Chodosh LA; Gunther EJ; Hilsenbeck SG; Rosen JM; Vargo-Gogola T
Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838
[TBL] [Abstract][Full Text] [Related]
34. Intravital Förster resonance energy transfer imaging reveals osteopontin-mediated polymorphonuclear leukocyte activation by tumor cell emboli.
Kamioka Y; Takakura K; Sumiyama K; Matsuda M
Cancer Sci; 2017 Feb; 108(2):226-235. PubMed ID: 27960041
[TBL] [Abstract][Full Text] [Related]
35. Steroid receptor coactivator 1 deficiency increases MMTV-neu mediated tumor latency and differentiation specific gene expression, decreases metastasis, and inhibits response to PPAR ligands.
Han JS; Crowe DL
BMC Cancer; 2010 Nov; 10():629. PubMed ID: 21080969
[TBL] [Abstract][Full Text] [Related]
36. Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity.
Muthuswamy SK; Siegel PM; Dankort DL; Webster MA; Muller WJ
Mol Cell Biol; 1994 Jan; 14(1):735-43. PubMed ID: 7903421
[TBL] [Abstract][Full Text] [Related]
37. mTORC1 upregulation via ERK-dependent gene expression change confers intrinsic resistance to MEK inhibitors in oncogenic KRas-mutant cancer cells.
Komatsu N; Fujita Y; Matsuda M; Aoki K
Oncogene; 2015 Nov; 34(45):5607-16. PubMed ID: 25703330
[TBL] [Abstract][Full Text] [Related]
38. Metformin selectively targets tumor-initiating cells in ErbB2-overexpressing breast cancer models.
Zhu P; Davis M; Blackwelder AJ; Bachman N; Liu B; Edgerton S; Williams LL; Thor AD; Yang X
Cancer Prev Res (Phila); 2014 Feb; 7(2):199-210. PubMed ID: 24322659
[TBL] [Abstract][Full Text] [Related]
39. Live imaging of transgenic mice expressing FRET biosensors.
Kamioka Y; Sumiyama K; Mizuno R; Matsuda M
Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():125-8. PubMed ID: 24109640
[TBL] [Abstract][Full Text] [Related]
40. Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.
Wellberg EA; Rudolph MC; Lewis AS; Padilla-Just N; Jedlicka P; Anderson SM
Breast Cancer Res; 2014 Dec; 16(6):481. PubMed ID: 25472762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
